{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:54:26Z","timestamp":1789800866915,"version":"4.0.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11537"],"award-info":[{"award-number":["25K11537"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","award":["SRG2023"],"award-info":[{"award-number":["SRG2023"]}],"id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is a global health burden associated with increasing mortality rates. Aging populations and declining fertility rates exacerbate this issue, particularly in countries such as Japan. Acute kidney injury (AKI) was previously considered temporary and reversible condition. However, in recent years, multiple studies on kidney diseases have shown that AKI survivors are at an increased risk of developing CKD. During the AKI-to-CKD transition, a subset of AKI-induced epigenetic alterations persists in cells, potentially driving the progression of tubulointerstitial fibrosis. Therefore, targeting epigenetic mechanisms may represent a promising therapeutic approach for preventing AKI-to-CKD transition. Among the epigenetic mechnisms involved, \u201chypoxic memory\u201d plays a crucial role in this transition by inducing persistent epigenetic changes. Hypoxic memory induces DNA methylation, histone modification, changes in chromatin conformation, and long non-codingRNA (lncRNA) expression. Herein, we review the latest evidence on epigenetic memory in the AKI-to-CKD transition, identifying that the detailed mechanisms of epigenetic memory and temporal specificity are crucial for developing effective treatments.<\/jats:p>","DOI":"10.1007\/s10157-025-02745-1","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T05:35:27Z","timestamp":1755668127000},"page":"1712-1723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epigenetic memories induced by hypoxia in AKI-to-CKD transition"],"prefix":"10.1007","volume":"29","author":[{"given":"Giyoung","family":"Kwoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3454-5127","authenticated-orcid":false,"given":"Imari","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"1","key":"2745_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003.","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"2745_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442\u20138. https:\/\/doi.org\/10.1038\/ki.2011.379.","journal-title":"Kidney Int"},{"key":"2745_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcrc.2018.11.028","volume":"50","author":"S Lee","year":"2019","unstructured":"Lee S, Park S, Kang MW, Yoo HW, Han K, Kim Y, et al. Postdischarge long-term cardiovascular outcomes of intensive care unit survivors who developed dialysis-requiring acute kidney injury after cardiac surgery. J Crit Care. 2019;50:92\u20138. https:\/\/doi.org\/10.1016\/j.jcrc.2018.11.028.","journal-title":"J Crit Care"},{"issue":"3","key":"2745_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1681\/ASN.2013060610","volume":"25","author":"VC Wu","year":"2014","unstructured":"Wu VC, Wu CH, Huang TM, Wang CY, Lai CF, Shiao CC, et al. Long-term risk of coronary events after AKI. J Am Soc Nephrol. 2014;25(3):595\u2013605. https:\/\/doi.org\/10.1681\/ASN.2013060610.","journal-title":"J Am Soc Nephrol"},{"key":"2745_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216152","author":"C Andre","year":"2023","unstructured":"Andre C, Bodeau S, Kamel S, Bennis Y, Caillard P. The AKI-to-CKD transition: the role of uremic toxins. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242216152.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2745_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188349","volume":"1873","author":"S Thiagalingam","year":"2020","unstructured":"Thiagalingam S. Epigenetic memory in development and disease: unraveling the mechanism. Biochim Biophys Acta (BBA). 2020;1873(2): 188349. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188349.","journal-title":"Biochim Biophys Acta (BBA)"},{"issue":"6","key":"2745_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tig.2014.04.004","volume":"30","author":"A D'Urso","year":"2014","unstructured":"D\u2019Urso A, Brickner JH. Mechanisms of epigenetic memory. Trends Genet. 2014;30(6):230\u20136. https:\/\/doi.org\/10.1016\/j.tig.2014.04.004.","journal-title":"Trends Genet"},{"issue":"2","key":"2745_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2745_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.10.031","author":"I Mimura","year":"2024","unstructured":"Mimura I, Chen Z, Natarajan R. Epigenetic alterations and memory: key players in the development\/progression of chronic kidney disease promoted by acute kidney injury and diabetes. Kidney Int. 2024. https:\/\/doi.org\/10.1016\/j.kint.2024.10.031.","journal-title":"Kidney Int"},{"issue":"4","key":"2745_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693\u2013705. https:\/\/doi.org\/10.1016\/j.cell.2007.02.005.","journal-title":"Cell"},{"issue":"4","key":"2745_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41581-018-0103-6","volume":"15","author":"C Guo","year":"2019","unstructured":"Guo C, Dong G, Liang X, Dong Z. Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications. Nat Rev Nephrol. 2019;15(4):220\u201339. https:\/\/doi.org\/10.1038\/s41581-018-0103-6.","journal-title":"Nat Rev Nephrol"},{"key":"2745_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","volume":"76","author":"MD Shahbazian","year":"2007","unstructured":"Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem. 2007;76:75\u2013100. https:\/\/doi.org\/10.1146\/annurev.biochem.76.052705.162114.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"2745_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s000180050121","volume":"54","author":"CA Mizzen","year":"1998","unstructured":"Mizzen CA, Allis CD. Linking histone acetylation to transcriptional regulation. Cell Mol Life Sci. 1998;54(1):6\u201320. https:\/\/doi.org\/10.1007\/s000180050121.","journal-title":"Cell Mol Life Sci"},{"issue":"14","key":"2745_CR14","doi-asserted-by":"publisher","first-page":"12579","DOI":"10.1074\/jbc.M213093200","volume":"278","author":"C Henderson","year":"2003","unstructured":"Henderson C, Mizzau M, Paroni G, Maestro R, Schneider C, Brancolini C. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem. 2003;278(14):12579\u201389. https:\/\/doi.org\/10.1074\/jbc.M213093200.","journal-title":"J Biol Chem"},{"issue":"5","key":"2745_CR15","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1128\/MCB.25.5.1608-1619.2005","volume":"25","author":"H Duan","year":"2005","unstructured":"Duan H, Heckman CA, Boxer LM. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol. 2005;25(5):1608\u201319. https:\/\/doi.org\/10.1128\/MCB.25.5.1608-1619.2005.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2745_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1124\/jpet.110.168385","volume":"335","author":"M Pang","year":"2010","unstructured":"Pang M, Zhuang S. Histone deacetylase: a potential therapeutic target for fibrotic disorders. J Pharmacol Exp Ther. 2010;335(2):266\u201372. https:\/\/doi.org\/10.1124\/jpet.110.168385.","journal-title":"J Pharmacol Exp Ther"},{"key":"2745_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218198","author":"K Ranganna","year":"2020","unstructured":"Ranganna K, Selvam C, Shivachar A, Yousefipour Z. Histone deacetylase inhibitors as multitarget-directed epi-drugs in blocking PI3K oncogenic signaling: a polypharmacology approach. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21218198.","journal-title":"Int J Mol Sci"},{"key":"2745_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060731","author":"AK Singh","year":"2018","unstructured":"Singh AK, Bishayee A, Pandey AK. Targeting histone deacetylases with natural and synthetic agents: an emerging anticancer strategy. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10060731.","journal-title":"Nutrients"},{"issue":"4","key":"2745_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4103\/0019-5154.160511","volume":"60","author":"AK Bubna","year":"2015","unstructured":"Bubna AK. Vorinostat\u2014an overview. Indian J Dermatol. 2015;60(4):419. https:\/\/doi.org\/10.4103\/0019-5154.160511.","journal-title":"Indian J Dermatol"},{"issue":"5","key":"2745_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019133","volume":"6","author":"E Li","year":"2014","unstructured":"Li E, Zhang Y. DNA methylation in mammals. Cold Spring Harb Perspect Biol. 2014;6(5): a019133. https:\/\/doi.org\/10.1101\/cshperspect.a019133.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"2745_CR21","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/nar\/26.11.2536","volume":"26","author":"M Okano","year":"1998","unstructured":"Okano M, Xie S, Li E. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 1998;26(11):2536\u201340. https:\/\/doi.org\/10.1093\/nar\/26.11.2536.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2745_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247\u201357. https:\/\/doi.org\/10.1016\/s0092-8674(00)81656-6.","journal-title":"Cell"},{"issue":"3","key":"2745_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00441-014-1884-y","volume":"356","author":"W Bechtel-Walz","year":"2014","unstructured":"Bechtel-Walz W, Huber TB. Chromatin dynamics in kidney development and function. Cell Tissue Res. 2014;356(3):601\u20138. https:\/\/doi.org\/10.1007\/s00441-014-1884-y.","journal-title":"Cell Tissue Res"},{"key":"2745_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-3-33","volume":"3","author":"CG Bell","year":"2010","unstructured":"Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics. 2010;3: 33. https:\/\/doi.org\/10.1186\/1755-8794-3-33.","journal-title":"BMC Med Genomics"},{"issue":"10","key":"2745_CR25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s43018-021-00249-x","volume":"2","author":"MB Pappalardi","year":"2021","unstructured":"Pappalardi MB, Keenan K, Cockerill M, Kellner WA, Stowell A, Sherk C, et al. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nat Cancer. 2021;2(10):1002\u201317.","journal-title":"Nat Cancer"},{"issue":"4","key":"2745_CR26","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.clml.2018.02.005","volume":"18","author":"R El Fakih","year":"2018","unstructured":"El Fakih R, Komrokji R, Shaheen M, Almohareb F, Rasheed W, Hassanein M. Azacitidine use for myeloid neoplasms. Clin Lymphoma Myeloma Leuk. 2018;18(4):e147\u201355. https:\/\/doi.org\/10.1016\/j.clml.2018.02.005.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"35","key":"2745_CR27","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK. 5-azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21(35):5483\u201395. https:\/\/doi.org\/10.1038\/sj.onc.1205699.","journal-title":"Oncogene"},{"issue":"5","key":"2745_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009;10(5):295\u2013304. https:\/\/doi.org\/10.1038\/nrg2540.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"2745_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/ng1158","volume":"34","author":"T Hashimshony","year":"2003","unstructured":"Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H. The role of DNA methylation in setting up chromatin structure during development. Nat Genet. 2003;34(2):187\u201392. https:\/\/doi.org\/10.1038\/ng1158.","journal-title":"Nat Genet"},{"issue":"6696","key":"2745_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/29680","volume":"394","author":"S Eden","year":"1998","unstructured":"Eden S, Hashimshony T, Keshet I, Cedar H, Thorne AW. DNA methylation models histone acetylation. Nature. 1998;394(6696):842. https:\/\/doi.org\/10.1038\/29680.","journal-title":"Nature"},{"issue":"3","key":"2745_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/15592294.2019.1666649","volume":"15","author":"K Fu","year":"2020","unstructured":"Fu K, Bonora G, Pellegrini M. Interactions between core histone marks and DNA methyltransferases predict DNA methylation patterns observed in human cells and tissues. Epigenetics. 2020;15(3):272\u201382. https:\/\/doi.org\/10.1080\/15592294.2019.1666649.","journal-title":"Epigenetics"},{"issue":"7618","key":"2745_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature19081","volume":"537","author":"B Thienpont","year":"2016","unstructured":"Thienpont B, Steinbacher J, Zhao H, D\u2019Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537(7618):63\u20138. https:\/\/doi.org\/10.1038\/nature19081.","journal-title":"Nature"},{"issue":"5","key":"2745_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm3327","volume":"13","author":"SM Kooistra","year":"2012","unstructured":"Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol. 2012;13(5):297\u2013311. https:\/\/doi.org\/10.1038\/nrm3327.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"2745_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374. https:\/\/doi.org\/10.1038\/nrg3074.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"2745_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41582-018-0065-0","volume":"14","author":"H Wood","year":"2018","unstructured":"Wood H. FDA approves patisiran to treat hereditary transthyretin amyloidosis. Nat Rev Neurol. 2018;14(10):570. https:\/\/doi.org\/10.1038\/s41582-018-0065-0.","journal-title":"Nat Rev Neurol"},{"issue":"16","key":"2745_CR36","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1111\/febs.16794","volume":"290","author":"H Saigusa","year":"2023","unstructured":"Saigusa H, Mimura I, Kurata Y, Tanaka T, Nangaku M. Hypoxia-inducible lncRNA MIR210HG promotes HIF1alpha expression by inhibiting miR-93-5p in renal tubular cells. FEBS J. 2023;290(16):4040\u201356. https:\/\/doi.org\/10.1111\/febs.16794.","journal-title":"FEBS J"},{"issue":"1","key":"2745_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1): 52. https:\/\/doi.org\/10.1038\/s41572-021-00284-z.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2745_CR38","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010006","volume":"26","author":"MA Venkatachalam","year":"2015","unstructured":"Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26(8):1765\u201376. https:\/\/doi.org\/10.1681\/ASN.2015010006.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2745_CR39","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","volume":"311","author":"RL Chevalier","year":"2016","unstructured":"Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol. 2016;311(1):F145\u201361. https:\/\/doi.org\/10.1152\/ajprenal.00164.2016.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"2745_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000476078","volume":"137","author":"M Nangaku","year":"2017","unstructured":"Nangaku M, Hirakawa Y, Mimura I, Inagi R, Tanaka T. Epigenetic changes in the acute kidney injury-to-chronic kidney disease transition. Nephron. 2017;137(4):256\u20139. https:\/\/doi.org\/10.1159\/000476078.","journal-title":"Nephron"},{"issue":"11","key":"2745_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrneph.2010.124","volume":"6","author":"I Mimura","year":"2010","unstructured":"Mimura I, Nangaku M. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol. 2010;6(11):667\u201378. https:\/\/doi.org\/10.1038\/nrneph.2010.124.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2745_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ajpath.2012.09.017","volume":"182","author":"A Havasi","year":"2013","unstructured":"Havasi A, Haegele JA, Gall JM, Blackmon S, Ichimura T, Bonegio RG, et al. Histone acetyl transferase (HAT) HBO1 and JADE1 in epithelial cell regeneration. Am J Pathol. 2013;182(1):152\u201362. https:\/\/doi.org\/10.1016\/j.ajpath.2012.09.017.","journal-title":"Am J Pathol"},{"issue":"7","key":"2745_CR43","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1681\/ASN.2007091040","volume":"19","author":"T Marumo","year":"2008","unstructured":"Marumo T, Hishikawa K, Yoshikawa M, Fujita T. Epigenetic regulation of BMP7 in the regenerative response to ischemia. J Am Soc Nephrol. 2008;19(7):1311\u201320. https:\/\/doi.org\/10.1681\/ASN.2007091040.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2745_CR44","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1681\/ASN.2009070690","volume":"21","author":"HF Li","year":"2010","unstructured":"Li HF, Cheng CF, Liao WJ, Lin H, Yang RB. ATF3-mediated epigenetic regulation protects against acute kidney injury. J Am Soc Nephrol. 2010;21(6):1003\u201313. https:\/\/doi.org\/10.1681\/ASN.2009070690.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2745_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4161\/15592294.2014.990780","volume":"10","author":"J Huang","year":"2015","unstructured":"Huang J, Wan D, Li J, Chen H, Huang K, Zheng L. Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury. Epigenetics. 2015;10(1):62\u201372. https:\/\/doi.org\/10.4161\/15592294.2014.990780.","journal-title":"Epigenetics"},{"issue":"1","key":"2745_CR46","doi-asserted-by":"publisher","first-page":"F61","DOI":"10.1152\/ajprenal.00015.2013","volume":"305","author":"JI Kim","year":"2013","unstructured":"Kim JI, Jung KJ, Jang HS, Park KM. Gender-specific role of HDAC11 in kidney ischemia- and reperfusion-induced PAI-1 expression and injury. Am J Physiol Renal Physiol. 2013;305(1):F61-70. https:\/\/doi.org\/10.1152\/ajprenal.00015.2013.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"2745_CR47","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1681\/ASN.2015040457","volume":"27","author":"X Zhou","year":"2016","unstructured":"Zhou X, Zang X, Ponnusamy M, Masucci MV, Tolbert E, Gong R, et al. Enhancer of zeste homolog 2 inhibition attenuates renal fibrosis by maintaining Smad7 and phosphatase and tensin homolog expression. J Am Soc Nephrol. 2016;27(7):2092\u2013108. https:\/\/doi.org\/10.1681\/ASN.2015040457.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2745_CR48","doi-asserted-by":"publisher","first-page":"fj201800237R","DOI":"10.1096\/fj.201800237R","volume":"32","author":"X Zhou","year":"2018","unstructured":"Zhou X, Xiong C, Tolbert E, Zhao TC, Bayliss G, Zhuang S. Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis. FASEB J. 2018;32(11):fj201800237R. https:\/\/doi.org\/10.1096\/fj.201800237R.","journal-title":"FASEB J"},{"issue":"7","key":"2745_CR49","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1681\/ASN.2007121368","volume":"19","author":"M Naito","year":"2008","unstructured":"Naito M, Bomsztyk K, Zager RA. Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. J Am Soc Nephrol. 2008;19(7):1321\u201330. https:\/\/doi.org\/10.1681\/ASN.2007121368.","journal-title":"J Am Soc Nephrol"},{"key":"2745_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00307","volume":"8","author":"TD Hewitson","year":"2017","unstructured":"Hewitson TD, Holt SG, Tan SJ, Wigg B, Samuel CS, Smith ER. Epigenetic modifications to H3K9 in renal tubulointerstitial cells after unilateral ureteric obstruction and TGF-\u03b21 stimulation. Front Pharmacol. 2017;8: 307. https:\/\/doi.org\/10.3389\/fphar.2017.00307.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2745_CR51","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/ndt\/gfp730","volume":"25","author":"SG Sayyed","year":"2010","unstructured":"Sayyed SG, Gaikwad AB, Lichtnekert J, Kulkarni O, Eulberg D, Klussmann S, et al. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol Dial Transplant. 2010;25(6):1811\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfp730.","journal-title":"Nephrol Dial Transplant"},{"key":"2745_CR52","doi-asserted-by":"publisher","first-page":"6635225","DOI":"10.1155\/2021\/6635225","volume":"2021","author":"H Xu","year":"2021","unstructured":"Xu H, Wu M, Ma X, Huang W, Xu Y. Function and mechanism of novel histone posttranslational modifications in health and disease. Biomed Res Int. 2021;2021:6635225. https:\/\/doi.org\/10.1155\/2021\/6635225.","journal-title":"Biomed Res Int"},{"key":"2745_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/bs.acc.2020.09.005","volume":"104","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang L, Yang Q, Zhang X, Li X. Epigenetics in kidney diseases. Adv Clin Chem. 2021;104:233\u201397. https:\/\/doi.org\/10.1016\/bs.acc.2020.09.005.","journal-title":"Adv Clin Chem"},{"issue":"6","key":"2745_CR54","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1242\/dmm.024455","volume":"9","author":"O Ruiz-Andres","year":"2016","unstructured":"Ruiz-Andres O, Sanchez-Nino MD, Cannata-Ortiz P, Ruiz-Ortega M, Egido J, Ortiz A, et al. Histone lysine crotonylation during acute kidney injury in mice. Dis Model Mech. 2016;9(6):633\u201345. https:\/\/doi.org\/10.1242\/dmm.024455.","journal-title":"Dis Model Mech"},{"issue":"Suppl 1","key":"2745_CR55","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.nephro.2016.02.005","volume":"12","author":"DA Ferenbach","year":"2016","unstructured":"Ferenbach DA, Bonventre JV. Acute kidney injury and chronic kidney disease: from the laboratory to the clinic. Nephrol Ther. 2016;12(Suppl 1):S41\u20138. https:\/\/doi.org\/10.1016\/j.nephro.2016.02.005.","journal-title":"Nephrol Ther"},{"issue":"6","key":"2745_CR56","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.semnephrol.2019.10.006","volume":"39","author":"MM Ullah","year":"2019","unstructured":"Ullah MM, Basile DP. Role of renal hypoxia in the progression from acute kidney injury to chronic kidney disease. Semin Nephrol. 2019;39(6):567\u201380. https:\/\/doi.org\/10.1016\/j.semnephrol.2019.10.006.","journal-title":"Semin Nephrol"},{"key":"2745_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020123","author":"F Tanemoto","year":"2022","unstructured":"Tanemoto F, Mimura I. Therapies targeting epigenetic alterations in acute kidney injury-to-chronic kidney disease transition. Pharmaceuticals (Basel). 2022. https:\/\/doi.org\/10.3390\/ph15020123.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"2745_CR58","doi-asserted-by":"publisher","first-page":"F1187","DOI":"10.1152\/ajprenal.00425.2014","volume":"307","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Tanaka T, Nangaku M. Hypoxia as a key player in the AKI-to-CKD transition. Am J Physiol Renal Physiol. 2014;307(11):F1187\u201395. https:\/\/doi.org\/10.1152\/ajprenal.00425.2014.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"2745_CR59","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/01.asn.0000018408.51388.57","volume":"13","author":"R Ohashi","year":"2002","unstructured":"Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol. 2002;13(7):1795\u2013805. https:\/\/doi.org\/10.1097\/01.asn.0000018408.51388.57.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2745_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1681\/ASN.V11147","volume":"11","author":"R Ohashi","year":"2000","unstructured":"Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol. 2000;11(1):47\u201356. https:\/\/doi.org\/10.1681\/ASN.V11147.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2745_CR61","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1053\/j.ajkd.2015.06.019","volume":"66","author":"L Zafrani","year":"2015","unstructured":"Zafrani L, Ince C. Microcirculation in acute and chronic kidney diseases. Am J Kidney Dis. 2015;66(6):1083\u201394. https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.019.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2745_CR62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2337\/diab.43.5.629","volume":"43","author":"A Korner","year":"1994","unstructured":"Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes. 1994;43(5):629\u201333. https:\/\/doi.org\/10.2337\/diab.43.5.629.","journal-title":"Diabetes"},{"issue":"2","key":"2745_CR63","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.semnephrol.2020.01.012","volume":"40","author":"IM Schiessl","year":"2020","unstructured":"Schiessl IM. The role of tubule-interstitial crosstalk in renal injury and recovery. Semin Nephrol. 2020;40(2):216\u201331. https:\/\/doi.org\/10.1016\/j.semnephrol.2020.01.012.","journal-title":"Semin Nephrol"},{"issue":"1","key":"2745_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00041552-200401000-00001","volume":"13","author":"DP Basile","year":"2004","unstructured":"Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens. 2004;13(1):1\u20137. https:\/\/doi.org\/10.1097\/00041552-200401000-00001.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"2745_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13023","volume":"222","author":"T Tanaka","year":"2018","unstructured":"Tanaka T. Epigenetic changes mediating transition to chronic kidney disease: hypoxic memory. Acta Physiol (Oxf). 2018;222(4): e13023. https:\/\/doi.org\/10.1111\/apha.13023.","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"2745_CR66","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrneph.2014.68","volume":"10","author":"HJ Anders","year":"2014","unstructured":"Anders HJ. Immune system modulation of kidney regeneration\u2013mechanisms and implications. Nat Rev Nephrol. 2014;10(6):347\u201358. https:\/\/doi.org\/10.1038\/nrneph.2014.68.","journal-title":"Nat Rev Nephrol"},{"key":"2745_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194941","author":"F Guzzi","year":"2019","unstructured":"Guzzi F, Cirillo L, Roperto RM, Romagnani P, Lazzeri E. Molecular mechanisms of the acute kidney injury to chronic kidney disease transition: an updated view. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20194941.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"2745_CR68","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/MCB.06643-11","volume":"32","author":"I Mimura","year":"2012","unstructured":"Mimura I, Nangaku M, Kanki Y, Tsutsumi S, Inoue T, Kohro T, et al. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mol Cell Biol. 2012;32(15):3018\u201332. https:\/\/doi.org\/10.1128\/MCB.06643-11.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2745_CR69","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1254\/jphs.10r19fm","volume":"115","author":"I Mimura","year":"2011","unstructured":"Mimura I, Tanaka T, Wada Y, Kodama T, Nangaku M. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymes. J Pharmacol Sci. 2011;115(4):453\u20138. https:\/\/doi.org\/10.1254\/jphs.10r19fm.","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"2745_CR70","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/1440-1681.12663","volume":"43","author":"I Mimura","year":"2016","unstructured":"Mimura I, Tanaka T, Nangaku M. New insights into molecular mechanisms of epigenetic regulation in kidney disease. Clin Exp Pharmacol Physiol. 2016;43(12):1159\u201367. https:\/\/doi.org\/10.1111\/1440-1681.12663.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2745_CR71","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13203","author":"I Mimura","year":"2017","unstructured":"Mimura I, Hirakawa Y, Kanki Y, Kushida N, Nakaki R, Suzuki Y, et al. Novel lnc RNA regulated by HIF-1 inhibits apoptotic cell death in the renal tubular epithelial cells under hypoxia. Physiol Rep. 2017. https:\/\/doi.org\/10.14814\/phy2.13203.","journal-title":"Physiol Rep"},{"key":"2745_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1003227","volume":"9","author":"F Tanemoto","year":"2022","unstructured":"Tanemoto F, Nangaku M, Mimura I. Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition. Front Mol Biosci. 2022;9: 1003227. https:\/\/doi.org\/10.3389\/fmolb.2022.1003227.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"2745_CR73","doi-asserted-by":"publisher","first-page":"F1032","DOI":"10.1152\/ajprenal.00061.2009","volume":"296","author":"RA Zager","year":"2009","unstructured":"Zager RA, Johnson AC. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory\/profibrotic genes. Am J Physiol Renal Physiol. 2009;296(5):F1032\u201341. https:\/\/doi.org\/10.1152\/ajprenal.00061.2009.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2745_CR74","doi-asserted-by":"publisher","first-page":"F827","DOI":"10.1152\/ajprenal.00683.2009","volume":"298","author":"RA Zager","year":"2010","unstructured":"Zager RA, Johnson AC. Progressive histone alterations and proinflammatory gene activation: consequences of heme protein\/iron-mediated proximal tubule injury. Am J Physiol Renal Physiol. 2010;298(3):F827\u201337. https:\/\/doi.org\/10.1152\/ajprenal.00683.2009.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"2745_CR75","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1681\/ASN.2009010118","volume":"20","author":"M Naito","year":"2009","unstructured":"Naito M, Zager RA, Bomsztyk K. BRG1 increases transcription of proinflammatory genes in renal ischemia. J Am Soc Nephrol. 2009;20(8):1787\u201396. https:\/\/doi.org\/10.1681\/ASN.2009010118.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2745_CR76","doi-asserted-by":"publisher","first-page":"F1334","DOI":"10.1152\/ajprenal.00431.2011","volume":"301","author":"RA Zager","year":"2011","unstructured":"Zager RA, Johnson AC, Becker K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and \u201cend-stage\u201d kidney disease. Am J Physiol Renal Physiol. 2011;301(6):F1334\u201345. https:\/\/doi.org\/10.1152\/ajprenal.00431.2011.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2745_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102939","volume":"68","author":"L Zhang","year":"2023","unstructured":"Zhang L, Chen F, Dong J, Wang R, Bi G, Xu D, et al. Hdac3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression. Redox Biol. 2023;68: 102939. https:\/\/doi.org\/10.1016\/j.redox.2023.102939.","journal-title":"Redox Biol"},{"issue":"4","key":"2745_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05782-4","volume":"14","author":"X Zhou","year":"2023","unstructured":"Zhou X, Chen H, Hu Y, Ma X, Li J, Shi Y, et al. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization. Cell Death Dis. 2023;14(4): 253. https:\/\/doi.org\/10.1038\/s41419-023-05782-4.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2745_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22180-5","volume":"8","author":"I Mimura","year":"2018","unstructured":"Mimura I, Hirakawa Y, Kanki Y, Nakaki R, Suzuki Y, Tanaka T, et al. Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes. Sci Rep. 2018;8(1): 3779. https:\/\/doi.org\/10.1038\/s41598-018-22180-5.","journal-title":"Sci Rep"},{"issue":"17","key":"2745_CR80","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15810","volume":"11","author":"T Yamazaki","year":"2023","unstructured":"Yamazaki T, Mimura I, Kurata Y, Tanaka T, Nangaku M. Dznep, a histone modification inhibitor, inhibits HIF1alpha binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia. Physiol Rep. 2023;11(17): e15810. https:\/\/doi.org\/10.14814\/phy2.15810.","journal-title":"Physiol Rep"},{"key":"2745_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gene.2017.02.005","volume":"610","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Ding C, Xue W, Ding X, Zheng J, Gao Y, et al. Genome-wide DNA methylation analysis in renal ischemia reperfusion injury. Gene. 2017;610:32\u201343. https:\/\/doi.org\/10.1016\/j.gene.2017.02.005.","journal-title":"Gene"},{"issue":"1","key":"2745_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22368-w","volume":"12","author":"Y Muto","year":"2021","unstructured":"Muto Y, Wilson PC, Ledru N, Wu H, Dimke H, Waikar SS, et al. Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney. Nat Commun. 2021;12(1): 2190. https:\/\/doi.org\/10.1038\/s41467-021-22368-w.","journal-title":"Nat Commun"},{"key":"2745_CR83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026684118","author":"LMS Gerhardt","year":"2021","unstructured":"Gerhardt LMS, Liu J, Koppitch K, Cippa PE, McMahon AP. Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2026684118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2745_CR84","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.7150\/thno.82582","volume":"13","author":"F Liu","year":"2023","unstructured":"Liu F, Wang Y, Gu H, Wang X. Technologies and applications of single-cell DNA methylation sequencing. Theranostics. 2023;13(8):2439\u201354. https:\/\/doi.org\/10.7150\/thno.82582.","journal-title":"Theranostics"},{"issue":"1","key":"2745_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39549-4","volume":"14","author":"N Rappoport","year":"2023","unstructured":"Rappoport N, Chomsky E, Nagano T, Seibert C, Lubling Y, Baran Y, et al. Single cell Hi-C identifies plastic chromosome conformations underlying the gastrulation enhancer landscape. Nat Commun. 2023;14(1): 3844. https:\/\/doi.org\/10.1038\/s41467-023-39549-4.","journal-title":"Nat Commun"},{"issue":"6","key":"2745_CR86","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41588-019-0424-9","volume":"51","author":"K Grosselin","year":"2019","unstructured":"Grosselin K, Durand A, Marsolier J, Poitou A, Marangoni E, Nemati F, et al. High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer. Nat Genet. 2019;51(6):1060\u20136. https:\/\/doi.org\/10.1038\/s41588-019-0424-9.","journal-title":"Nat Genet"},{"issue":"1","key":"2745_CR87","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.1038\/s41598-021-88000-5","volume":"11","author":"A Sanchez-Navarro","year":"2021","unstructured":"Sanchez-Navarro A, Perez-Villalva R, Murillo-de-Ozores AR, Martinez-Rojas MA, Rodriguez-Aguilera JR, Gonzalez N, et al. Vegfa promoter gene hypermethylation at HIF1\u03b1 binding site is an early contributor to CKD progression after renal ischemia. Sci Rep. 2021;11(1):8769. https:\/\/doi.org\/10.1038\/s41598-021-88000-5.","journal-title":"Sci Rep"},{"issue":"21","key":"2745_CR88","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2217\/epi-2023-0281","volume":"15","author":"SM Fadul","year":"2023","unstructured":"Fadul SM, Arshad A, Mehmood R. CRISPR-based epigenome editing: mechanisms and applications. Epigenomics. 2023;15(21):1137\u201355. https:\/\/doi.org\/10.2217\/epi-2023-0281.","journal-title":"Epigenomics"},{"key":"2745_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2024.1304110","volume":"6","author":"JJ Waldo","year":"2024","unstructured":"Waldo JJ, Halmai J, Fink KD. Epigenetic editing for autosomal dominant neurological disorders. Front Genome Ed. 2024;6: 1304110. https:\/\/doi.org\/10.3389\/fgeed.2024.1304110.","journal-title":"Front Genome Ed"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02745-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02745-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02745-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:29:46Z","timestamp":1764235786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02745-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2745"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02745-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}